Your browser doesn't support javascript.
loading
The Cantabria Cohort, a protocol for a population-based cohort in northern Spain.
Alonso-Peña, Marta; Dierssen, Trinidad; Marin, Maria José; Alonso-Molero, Jessica; Gómez-Acebo, Inés; Santiuste, Inés; Lazarus, Jeffrey V; Sanchez-Juan, Pascual; Peralta, Galo; Crespo, Javier; Lopez-Hoyos, Marcos.
Afiliación
  • Alonso-Peña M; Valdecilla Research Institute (IDIVAL), Santander, 39011, Spain. malonso@idival.org.
  • Dierssen T; Valdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
  • Marin MJ; Faculty of Medicine, University of Cantabria, Santander, 39011, Spain.
  • Alonso-Molero J; Valdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
  • Gómez-Acebo I; Valdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
  • Santiuste I; Faculty of Medicine, University of Cantabria, Santander, 39011, Spain.
  • Lazarus JV; Valdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
  • Sanchez-Juan P; Faculty of Medicine, University of Cantabria, Santander, 39011, Spain.
  • Peralta G; Valdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
  • Crespo J; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Lopez-Hoyos M; CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA.
BMC Public Health ; 23(1): 2429, 2023 12 05.
Article en En | MEDLINE | ID: mdl-38053113
Cantabria Cohort stems from a research and action initiative lead by researchers from Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital and University of Cantabria, supported by the regional Goverment. Its aim is to identify and follow up a cohort that would provide information to improve the understanding of the etiology and prognosis of different acute and chronic diseases. The Cantabria Cohort will recruit between 40,000-50,000 residents aged 40-69 years at baseline, representing 10-20% of the target population. Currently, more than 30,000 volunteers have been enrolled. All participants will be invited for a re-assessment every three years, while the overall duration is planned for twenty years. The repeated collection of biomaterials combined with broad information from participant questionnaires, medical examinations, actual health system records and other secondary public data sources is a major strength of its design, which will make it possible to address biological pathways of disease development, identify new factors involved in health and disease, design new strategies for disease prevention, and advance precision medicine. It is conceived to allow access to a large number of researchers worldwide to boost collaboration and medical research.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Atención a la Salud Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMC Public Health Asunto de la revista: SAUDE PUBLICA Año: 2023 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Atención a la Salud Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMC Public Health Asunto de la revista: SAUDE PUBLICA Año: 2023 Tipo del documento: Article País de afiliación: España